

The incidence is likely higher when using high-sensitivity cTn assays and evaluating populations with higher illness severity compared to when using contemporary assays and evaluating populations with lower illness severity.

The exact frequency of myocardial injury in patients with COVID-19 is difficult to ascertain due to variations in cTn assays and thresholds used, studied populations, as well as the number and timing of samples obtained.
